Knowledge Distillery

Over one year after its inception, the coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2…

Characterizing the kinetics of the antibody response to SARS‐CoV‐2 is of critical importance to developing strategies that may mitigate the public…

The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension exists that variants of concern (VOCs) may evade vaccine…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve around the world, generating new variants that are of concern based…

SARS-CoV-2 variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection.

The Ad26.COV2.S vaccine has demonstrated clinical efficacy against symptomatic COVID-19, including against the B.1.351 variant that is partially…

Coronavirus disease (COVID-19) has been associated with a large variety of neurologic disorders. However, the mechanisms underlying these neurologic…

The objective of this study was to explore the spectrum of skeletal muscle and nerve pathology of patients who died following SARS-CoV-2 infection and…

Whilst SARS-CoV-2 vaccines are very safe, in this brief communication the authors report four cases of the bifacial weakness with paraesthesias…

As of April 22, 2021, around 1.5 million individuals in 3 districts of Kerala, India had been vaccinated with COVID-19 vaccines.

The objective of this study was to evaluate potential predictive factors of smell recovery in a clinical series of 288 patients presenting olfactory…

Limited information is available on incidence and outcomes of COVID-19 in patients with multiple sclerosis (MS). This study investigated the risks of…